Global Muscle Relaxant Drugs Market Insights and Forecast to 2026
- BMR3911166
- 150 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Muscle Relaxant Drugs was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Muscle Relaxant Drugs is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Muscle Relaxant Drugs market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Muscle Relaxant Drugs market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Muscle Relaxant Drugs industry.
Global Muscle Relaxant Drugs Scope and Segment
Muscle Relaxant Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Muscle Relaxant Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical
Muscle Relaxant Drugs Breakdown Data by Type
Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs
Muscle Relaxant Drugs Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Other
Regional and Country-level Analysis
The Muscle Relaxant Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Muscle Relaxant Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Muscle Relaxant Drugs Market Share Analysis
1.1 Muscle Relaxant Drugs Product Introduction
1.2 Market Segments
1.3 Key Muscle Relaxant Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Muscle Relaxant Drugs Market Size Growth Rate by Type
1.4.2 Skeletal Muscle Relaxant Drugs
1.4.3 Facial Muscle Relaxant Drugs
1.5 Market by Application
1.5.1 Global Muscle Relaxant Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Muscle Relaxant Drugs Market Size, Estimates and Forecasts
2.1.1 Global Muscle Relaxant Drugs Revenue 2015-2026
2.1.2 Global Muscle Relaxant Drugs Sales 2015-2026
2.2 Global Muscle Relaxant Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Muscle Relaxant Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Muscle Relaxant Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Muscle Relaxant Drugs Competitor Landscape by Players
3.1 Muscle Relaxant Drugs Sales by Manufacturers
3.1.1 Muscle Relaxant Drugs Sales by Manufacturers (2015-2020)
3.1.2 Muscle Relaxant Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Muscle Relaxant Drugs Revenue by Manufacturers
3.2.1 Muscle Relaxant Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Muscle Relaxant Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Muscle Relaxant Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Muscle Relaxant Drugs Revenue in 2019
3.2.5 Global Muscle Relaxant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Muscle Relaxant Drugs Price by Manufacturers
3.4 Muscle Relaxant Drugs Manufacturing Base Distribution, Product Types
3.4.1 Muscle Relaxant Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Muscle Relaxant Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Muscle Relaxant Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Muscle Relaxant Drugs Market Size by Type (2015-2020)
4.1.1 Global Muscle Relaxant Drugs Sales by Type (2015-2020)
4.1.2 Global Muscle Relaxant Drugs Revenue by Type (2015-2020)
4.1.3 Muscle Relaxant Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Muscle Relaxant Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Muscle Relaxant Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Muscle Relaxant Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Muscle Relaxant Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Muscle Relaxant Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Muscle Relaxant Drugs Market Size by Application (2015-2020)
5.1.1 Global Muscle Relaxant Drugs Sales by Application (2015-2020)
5.1.2 Global Muscle Relaxant Drugs Revenue by Application (2015-2020)
5.1.3 Muscle Relaxant Drugs Price by Application (2015-2020)
5.2 Muscle Relaxant Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Muscle Relaxant Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Muscle Relaxant Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Muscle Relaxant Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Muscle Relaxant Drugs by Country
6.1.1 North America Muscle Relaxant Drugs Sales by Country
6.1.2 North America Muscle Relaxant Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Muscle Relaxant Drugs Market Facts & Figures by Type
6.3 North America Muscle Relaxant Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Muscle Relaxant Drugs by Country
7.1.1 Europe Muscle Relaxant Drugs Sales by Country
7.1.2 Europe Muscle Relaxant Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Muscle Relaxant Drugs Market Facts & Figures by Type
7.3 Europe Muscle Relaxant Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Muscle Relaxant Drugs by Region
8.1.1 Asia Pacific Muscle Relaxant Drugs Sales by Region
8.1.2 Asia Pacific Muscle Relaxant Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Muscle Relaxant Drugs Market Facts & Figures by Type
8.3 Asia Pacific Muscle Relaxant Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Muscle Relaxant Drugs by Country
9.1.1 Latin America Muscle Relaxant Drugs Sales by Country
9.1.2 Latin America Muscle Relaxant Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Muscle Relaxant Drugs Market Facts & Figures by Type
9.3 Central & South America Muscle Relaxant Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Muscle Relaxant Drugs by Country
10.1.1 Middle East and Africa Muscle Relaxant Drugs Sales by Country
10.1.2 Middle East and Africa Muscle Relaxant Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Muscle Relaxant Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Muscle Relaxant Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Muscle Relaxant Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Description and Business Overview
11.2.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Allergan Muscle Relaxant Drugs Products Offered
11.2.5 Allergan Related Developments
11.3 Ipsen Group
11.3.1 Ipsen Group Corporation Information
11.3.2 Ipsen Group Description and Business Overview
11.3.3 Ipsen Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ipsen Group Muscle Relaxant Drugs Products Offered
11.3.5 Ipsen Group Related Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Corporation Information
11.4.2 Teva Pharmaceuticals Description and Business Overview
11.4.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Pharmaceuticals Muscle Relaxant Drugs Products Offered
11.4.5 Teva Pharmaceuticals Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Muscle Relaxant Drugs Products Offered
11.5.5 Novartis Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Muscle Relaxant Drugs Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Description and Business Overview
11.7.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Takeda Pharmaceutical Muscle Relaxant Drugs Products Offered
11.7.5 Takeda Pharmaceutical Related Developments
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Corporation Information
11.8.2 Sun Pharmaceutical Industries Description and Business Overview
11.8.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sun Pharmaceutical Industries Muscle Relaxant Drugs Products Offered
11.8.5 Sun Pharmaceutical Industries Related Developments
11.9 Merz Pharma
11.9.1 Merz Pharma Corporation Information
11.9.2 Merz Pharma Description and Business Overview
11.9.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merz Pharma Muscle Relaxant Drugs Products Offered
11.9.5 Merz Pharma Related Developments
11.10 Mylan
11.10.1 Mylan Corporation Information
11.10.2 Mylan Description and Business Overview
11.10.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Mylan Muscle Relaxant Drugs Products Offered
11.10.5 Mylan Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Muscle Relaxant Drugs Products Offered
11.1.5 Pfizer Related Developments
11.12 Endo International
11.12.1 Endo International Corporation Information
11.12.2 Endo International Description and Business Overview
11.12.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Endo International Products Offered
11.12.5 Endo International Related Developments
11.13 Par Sterile Products
11.13.1 Par Sterile Products Corporation Information
11.13.2 Par Sterile Products Description and Business Overview
11.13.3 Par Sterile Products Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Par Sterile Products Products Offered
11.13.5 Par Sterile Products Related Developments
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Corporation Information
11.14.2 Acorda Therapeutics Description and Business Overview
11.14.3 Acorda Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Acorda Therapeutics Products Offered
11.14.5 Acorda Therapeutics Related Developments
11.15 SteriMax Inc
11.15.1 SteriMax Inc Corporation Information
11.15.2 SteriMax Inc Description and Business Overview
11.15.3 SteriMax Inc Sales, Revenue and Gross Margin (2015-2020)
11.15.4 SteriMax Inc Products Offered
11.15.5 SteriMax Inc Related Developments
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Corporation Information
11.16.2 Emcure Pharmaceuticals Description and Business Overview
11.16.3 Emcure Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Emcure Pharmaceuticals Products Offered
11.16.5 Emcure Pharmaceuticals Related Developments
11.17 Upsher-Smith Laboratories
11.17.1 Upsher-Smith Laboratories Corporation Information
11.17.2 Upsher-Smith Laboratories Description and Business Overview
11.17.3 Upsher-Smith Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Upsher-Smith Laboratories Products Offered
11.17.5 Upsher-Smith Laboratories Related Developments
11.18 Orient Pharma
11.18.1 Orient Pharma Corporation Information
11.18.2 Orient Pharma Description and Business Overview
11.18.3 Orient Pharma Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Orient Pharma Products Offered
11.18.5 Orient Pharma Related Developments
11.19 Daewoong Pharmaceutical
11.19.1 Daewoong Pharmaceutical Corporation Information
11.19.2 Daewoong Pharmaceutical Description and Business Overview
11.19.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Daewoong Pharmaceutical Products Offered
11.19.5 Daewoong Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Muscle Relaxant Drugs Market Estimates and Projections by Region
12.1.1 Global Muscle Relaxant Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Muscle Relaxant Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Muscle Relaxant Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Muscle Relaxant Drugs Sales Forecast (2021-2026)
12.2.2 North America: Muscle Relaxant Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Muscle Relaxant Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Muscle Relaxant Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Muscle Relaxant Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Muscle Relaxant Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Muscle Relaxant Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Muscle Relaxant Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Muscle Relaxant Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Muscle Relaxant Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Muscle Relaxant Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Muscle Relaxant Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Muscle Relaxant Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Muscle Relaxant Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Muscle Relaxant Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Muscle Relaxant Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Muscle Relaxant Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Muscle Relaxant Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Muscle Relaxant Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Muscle Relaxant Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Muscle Relaxant Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Muscle Relaxant Drugs Market Segments
Table 2. Ranking of Global Top Muscle Relaxant Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Muscle Relaxant Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Skeletal Muscle Relaxant Drugs
Table 5. Major Manufacturers of Facial Muscle Relaxant Drugs
Table 6. Global Muscle Relaxant Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Muscle Relaxant Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Muscle Relaxant Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Muscle Relaxant Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Muscle Relaxant Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Muscle Relaxant Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Muscle Relaxant Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Muscle Relaxant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Muscle Relaxant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Relaxant Drugs as of 2019)
Table 15. Muscle Relaxant Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Muscle Relaxant Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Muscle Relaxant Drugs Price (2015-2020) (USD/Unit)
Table 18. Muscle Relaxant Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Muscle Relaxant Drugs Product Type
Table 20. Date of International Manufacturers Enter into Muscle Relaxant Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Muscle Relaxant Drugs Sales Share by Type (2015-2020)
Table 24. Global Muscle Relaxant Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Muscle Relaxant Drugs Revenue Share by Type (2015-2020)
Table 26. Muscle Relaxant Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Muscle Relaxant Drugs Sales Share by Application (2015-2020)
Table 29. North America Muscle Relaxant Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Muscle Relaxant Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Muscle Relaxant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Muscle Relaxant Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Muscle Relaxant Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Muscle Relaxant Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Muscle Relaxant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Muscle Relaxant Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Muscle Relaxant Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Muscle Relaxant Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Muscle Relaxant Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Muscle Relaxant Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Muscle Relaxant Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Muscle Relaxant Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Muscle Relaxant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Muscle Relaxant Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Muscle Relaxant Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Muscle Relaxant Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Muscle Relaxant Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Muscle Relaxant Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Muscle Relaxant Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Muscle Relaxant Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Allergan Corporation Information
Table 75. Allergan Description and Major Businesses
Table 76. Allergan Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Allergan Product
Table 78. Allergan Recent Development
Table 79. Ipsen Group Corporation Information
Table 80. Ipsen Group Description and Major Businesses
Table 81. Ipsen Group Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Ipsen Group Product
Table 83. Ipsen Group Recent Development
Table 84. Teva Pharmaceuticals Corporation Information
Table 85. Teva Pharmaceuticals Description and Major Businesses
Table 86. Teva Pharmaceuticals Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Teva Pharmaceuticals Product
Table 88. Teva Pharmaceuticals Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Major Businesses
Table 96. Johnson & Johnson Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Recent Development
Table 99. Takeda Pharmaceutical Corporation Information
Table 100. Takeda Pharmaceutical Description and Major Businesses
Table 101. Takeda Pharmaceutical Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Takeda Pharmaceutical Product
Table 103. Takeda Pharmaceutical Recent Development
Table 104. Sun Pharmaceutical Industries Corporation Information
Table 105. Sun Pharmaceutical Industries Description and Major Businesses
Table 106. Sun Pharmaceutical Industries Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Sun Pharmaceutical Industries Product
Table 108. Sun Pharmaceutical Industries Recent Development
Table 109. Merz Pharma Corporation Information
Table 110. Merz Pharma Description and Major Businesses
Table 111. Merz Pharma Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Merz Pharma Product
Table 113. Merz Pharma Recent Development
Table 114. Mylan Corporation Information
Table 115. Mylan Description and Major Businesses
Table 116. Mylan Muscle Relaxant Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Mylan Product
Table 118. Mylan Recent Development
Table 119. Fresenius Kabi Corporation Information
Table 120. Fresenius Kabi Description and Major Businesses
Table 121. Fresenius Kabi Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Fresenius Kabi Product
Table 123. Fresenius Kabi Recent Development
Table 124. Endo International Corporation Information
Table 125. Endo International Description and Major Businesses
Table 126. Endo International Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Endo International Product
Table 128. Endo International Recent Development
Table 129. Par Sterile Products Corporation Information
Table 130. Par Sterile Products Description and Major Businesses
Table 131. Par Sterile Products Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Par Sterile Products Product
Table 133. Par Sterile Products Recent Development
Table 134. Acorda Therapeutics Corporation Information
Table 135. Acorda Therapeutics Description and Major Businesses
Table 136. Acorda Therapeutics Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Acorda Therapeutics Product
Table 138. Acorda Therapeutics Recent Development
Table 139. SteriMax Inc Corporation Information
Table 140. SteriMax Inc Description and Major Businesses
Table 141. SteriMax Inc Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. SteriMax Inc Product
Table 143. SteriMax Inc Recent Development
Table 144. Emcure Pharmaceuticals Corporation Information
Table 145. Emcure Pharmaceuticals Description and Major Businesses
Table 146. Emcure Pharmaceuticals Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Emcure Pharmaceuticals Product
Table 148. Emcure Pharmaceuticals Recent Development
Table 149. Upsher-Smith Laboratories Corporation Information
Table 150. Upsher-Smith Laboratories Description and Major Businesses
Table 151. Upsher-Smith Laboratories Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Upsher-Smith Laboratories Product
Table 153. Upsher-Smith Laboratories Recent Development
Table 154. Orient Pharma Corporation Information
Table 155. Orient Pharma Description and Major Businesses
Table 156. Orient Pharma Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Orient Pharma Product
Table 158. Orient Pharma Recent Development
Table 159. Daewoong Pharmaceutical Corporation Information
Table 160. Daewoong Pharmaceutical Description and Major Businesses
Table 161. Daewoong Pharmaceutical Muscle Relaxant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Daewoong Pharmaceutical Product
Table 163. Daewoong Pharmaceutical Recent Development
Table 164. Global Muscle Relaxant Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 165. Global Muscle Relaxant Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 166. Global Muscle Relaxant Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 167. Global Muscle Relaxant Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 168. North America: Muscle Relaxant Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 169. North America: Muscle Relaxant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Europe: Muscle Relaxant Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 171. Europe: Muscle Relaxant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 172. Asia Pacific: Muscle Relaxant Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 173. Asia Pacific: Muscle Relaxant Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 174. Latin America: Muscle Relaxant Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 175. Latin America: Muscle Relaxant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 176. Middle East and Africa: Muscle Relaxant Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 177. Middle East and Africa: Muscle Relaxant Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 178. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 179. Key Challenges
Table 180. Market Risks
Table 181. Main Points Interviewed from Key Muscle Relaxant Drugs Players
Table 182. Muscle Relaxant Drugs Customers List
Table 183. Muscle Relaxant Drugs Distributors List
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Muscle Relaxant Drugs Product Picture
Figure 2. Global Muscle Relaxant Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Skeletal Muscle Relaxant Drugs Product Picture
Figure 4. Facial Muscle Relaxant Drugs Product Picture
Figure 5. Global Muscle Relaxant Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Other
Figure 9. Muscle Relaxant Drugs Report Years Considered
Figure 10. Global Muscle Relaxant Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Muscle Relaxant Drugs Sales 2015-2026 (K Units)
Figure 12. Global Muscle Relaxant Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Muscle Relaxant Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Muscle Relaxant Drugs Sales Market Share by Region in 2019
Figure 15. Global Muscle Relaxant Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Muscle Relaxant Drugs Revenue Market Share by Region in 2019
Figure 17. Global Muscle Relaxant Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Muscle Relaxant Drugs Revenue in 2019
Figure 19. Muscle Relaxant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Muscle Relaxant Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Muscle Relaxant Drugs Sales Market Share by Type in 2019
Figure 22. Global Muscle Relaxant Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Muscle Relaxant Drugs Revenue Market Share by Type in 2019
Figure 24. Global Muscle Relaxant Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Muscle Relaxant Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Muscle Relaxant Drugs Sales Market Share by Application in 2019
Figure 27. Global Muscle Relaxant Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Muscle Relaxant Drugs Revenue Market Share by Application in 2019
Figure 29. North America Muscle Relaxant Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Muscle Relaxant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Muscle Relaxant Drugs Sales Market Share by Country in 2019
Figure 32. North America Muscle Relaxant Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Muscle Relaxant Drugs Market Share by Type in 2019
Figure 38. North America Muscle Relaxant Drugs Market Share by Application in 2019
Figure 39. Europe Muscle Relaxant Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Muscle Relaxant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Muscle Relaxant Drugs Sales Market Share by Country in 2019
Figure 42. Europe Muscle Relaxant Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Muscle Relaxant Drugs Market Share by Type in 2019
Figure 54. Europe Muscle Relaxant Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Muscle Relaxant Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Muscle Relaxant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Muscle Relaxant Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Muscle Relaxant Drugs Revenue Market Share by Region in 2019
Figure 59. China Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Muscle Relaxant Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Muscle Relaxant Drugs Market Share by Application in 2019
Figure 83. Latin America Muscle Relaxant Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Muscle Relaxant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Muscle Relaxant Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Muscle Relaxant Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Muscle Relaxant Drugs Market Share by Type in 2019
Figure 94. Latin America Muscle Relaxant Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Muscle Relaxant Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Muscle Relaxant Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Muscle Relaxant Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Muscle Relaxant Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Muscle Relaxant Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Muscle Relaxant Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Muscle Relaxant Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Muscle Relaxant Drugs Market Share by Application in 2019
Figure 107. North America Muscle Relaxant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Muscle Relaxant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Muscle Relaxant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Muscle Relaxant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Muscle Relaxant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Muscle Relaxant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Muscle Relaxant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Muscle Relaxant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Muscle Relaxant Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Muscle Relaxant Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
